Zepp Health (NYSE:ZEPP - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.
Separately, Fundamental Research set a $53.01 price objective on shares of Zepp Health and gave the stock a "buy" rating in a research note on Tuesday. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $53.01.
Check Out Our Latest Stock Analysis on Zepp Health
Zepp Health Trading Up 3.0%
Shares of Zepp Health stock opened at $5.52 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.67 and a current ratio of 0.88. The firm has a 50-day moving average of $4.98 and a 200-day moving average of $11.89. Zepp Health has a 52-week low of $3.85 and a 52-week high of $61.85. The stock has a market cap of $81.02 million, a PE ratio of -2.19 and a beta of 1.86.
Insiders Place Their Bets
In other news, CFO Cheng Deng sold 9,836 shares of the company's stock in a transaction on Friday, June 26th. The stock was sold at an average price of $4.61, for a total transaction of $45,343.96. Following the completion of the sale, the chief financial officer directly owned 114,539 shares in the company, valued at approximately $528,024.79. This represents a 7.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the stock. Public Employees Retirement System of Ohio raised its stake in Zepp Health by 61.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company's stock valued at $41,000 after purchasing an additional 576 shares in the last quarter. Harvest Fund Management Co. Ltd grew its stake in Zepp Health by 6.7% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company's stock worth $1,207,000 after buying an additional 2,800 shares in the last quarter. Osaic Holdings Inc. increased its holdings in Zepp Health by 239.5% in the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company's stock valued at $223,000 after buying an additional 5,845 shares during the period. Dimensional Fund Advisors LP bought a new position in Zepp Health in the 4th quarter valued at about $241,000. Finally, Capstone Capital Management Ltd acquired a new position in shares of Zepp Health in the 4th quarter valued at approximately $298,000. Institutional investors own 52.61% of the company's stock.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health's integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health's offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.